Wordt geladen…
The effectiveness and safety of Kami Guibi-tang for mild cognitive impairment: study protocol of a pilot, randomized, placebo-controlled, double-blind trial
BACKGROUND: Mild cognitive impairment (MCI) is an intermediate phase between normal aging and dementia. Since a majority of amnestic MCI (aMCI) cases progress to Alzheimer’s disease (AD), it is considered the prodromal stage of AD and, therefore, a treatment target for the prevention of further cogn...
Hoofdauteurs: | , , , , , , |
---|---|
Formaat: | Online Artikel Texto |
Taal: | English |
Gepubliceerd in: |
BioMed Central
2019
|
Onderwerpen: | |
Online toegang: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6647292/ https://www.ncbi.nlm.nih.gov/pubmed/31331367 http://dx.doi.org/10.1186/s13063-019-3567-1 |